Ennis, Ireland

Andrew Cunningham

This inventor holds 18 USPTO granted patents and 12 published patent applications and 2 EPO patents. Top assignee: Intel Corporation. Active years: 2019-2025.

USPTO Granted Patents = 18 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.7

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Santa Clara, CA (US) (2019)
  • Ennis, IE (2019 - 2024)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Journey of Andrew Cunningham

Introduction: Andrew Cunningham, a talented inventor hailing from Ennis, Ireland, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Andrew Cunningham's most recent patents include a cutting-edge software application for enhancing cybersecurity measures in financial institutions and a revolutionary medical device designed to improve patient care in hospitals.

Career Highlights: With over two decades of experience in the tech industry, Andrew has a proven track record of developing innovative solutions that have garnered international acclaim. His work has been instrumental in shaping the future of various sectors, from finance to healthcare.

Collaborations: Throughout his career, Andrew Cunningham has collaborated with leading research institutions and top-tier universities to push the boundaries of technological advancement. His partnerships have resulted in the development of cutting-edge products that have revolutionized the way we approach complex challenges.

Conclusion: Andrew Cunningham's passion for innovation and his relentless pursuit of excellence have established him as a visionary inventor in the world of technology. His dedication to creating solutions that make a positive impact on society sets him apart as a true pioneer in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…